Charlton Ralph William III 4
4 · SPRUCE BIOSCIENCES, INC. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Charlton Ralph William III
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-04-01+250,000→ 250,000 totalExercise: $2.13Exp: 2032-03-31→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period commencing on the vesting commencement date of March 28, 2022 ("Vesting Commencement Date"). 1/4th of the total number of shares will vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/36th of the remaining shares will vest and become exercisable on a monthly basis thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).